Cefepime and Mortality—A Dosing Problem, Not a Drug Problem

A meta-analysis of 110 trials found cefepime linked to higher 30-day mortality than other β-lactams, most clearly in adults, febrile neutropenia or severe infections, and at higher doses. That conflicts with the FDA’s earlier finding of no added risk. The authors and an accompanying commentary still don’t recommend dropping the drug. They call all-cause mortality a blunt outcome in critically ill patients, and suggest the deaths may reflect under- or overexposure rather than the drug itself. Cefepime’s safety margin is narrower than that of other β-lactams, so dosing matters. Urgent Care clinical implications: This shouldn’t change practice for typical Urgent Care use, but dose cefepime carefully for renal function and watch for neurotoxicity (confusion, myoclonus) in older adults. Full Access: JAMA

Infant Respiratory Syncytial Virus and Childhood Asthma: A Nationwide Registry-Based, Sibling-Controlled, And Genome-Wide Association Study

Researchers combined Finnish registry data on nearly 1 million children with Nordic genetic cohorts to ask whether severe infant RSV causes childhood asthma or just flags kids already prone to it. Children hospitalized with RSV in their first year had about 3.7 times the risk of later recurrent wheeze or asthma, and the link held in sibling comparisons. Unaffected siblings also had about double the usual rate, so family susceptibility plays a part too. RSV-related wheeze started earlier, needed more inhaled steroids at ages 1–2, faded after age 5, and came with lower eosinophils, which suggests a more transient, less allergic pattern. Urgent Care Clinical implications: Expect early, non-allergic wheeze in children with a history of RSV hospitalization, and reassess the need for controller therapy over time rather than assuming lifelong asthma. Ask about infant RSV history, and reassure families that many of these children improve by school age. Full Access: The Lancet

Most Americans Know How to Control Mosquitoes; Many Unsure How to Use Insect Repellent

A new Annenberg survey found that most people know the basics: 82% say preventing bites and controlling mosquitoes at home is the best defense against West Nile and dengue, and 64% routinely take precautions. Knowledge of how to use repellent is much weaker. Only 31% know to apply sunscreen first and repellent second, 15% know repellent shouldn’t go under clothing, and 18% know to look for an EPA-registered product. Only 16% worry about catching one of these diseases, and 56% can’t identify West Nile symptoms. The CDC has reported 504 human West Nile cases in 41 states so far this year, 363 of them neuroinvasive. Urgent Care Clinical implications: Clinicians should counsel on repellent: EPA-registered products, sunscreen first, nothing under clothing, none for infants under 2 months. Keep West Nile on the differential for febrile or neurologic presentations during mosquito season, since patients often won’t connect their symptoms to a bite. Full Access: APCC

Nationwide Increase in Reported Human Rabies Exposures: Rabies Post-exposure Prophylaxis Administration

CDC issued a Health Advisory on September 10 about a nationwide rise in rabies exposures and errors in post-exposure prophylaxis (PEP). Rabies inquiries to CDC were up 17% in July and August compared with last year, and use of rabies vaccine and HRIG rose about 33% and 76%. Supplies are fine, but mistakes lead to unnecessary treatment, adverse effects, and cost. The most common errors are gluteal vaccine injections, poor HRIG infiltration of wounds, mixing HRIG and vaccine in one syringe or site, and giving HRIG to previously vaccinated patients. Urgent Care Clinical implications: Do a careful risk assessment before starting PEP, check prior vaccination and immune status, and call your health department. Full Access: CDC

October 8, 2026

Each year, National PA Week provides an opportunity to recognize the remarkable contributions Physician Associates (PAs) make to patient care across the healthcare industry. In Urgent Care, their impact is especially significant.

PAs are often among the first healthcare professionals patients encounter when seeking care for illnesses, injuries and unexpected health concerns. Their clinical expertise, adaptability and commitment to patient-centered care help ensure patients receive timely, high-quality treatment when they need it most.

Beyond direct patient care, many PAs serve as leaders, educators, mentors and advocates within the Urgent Care profession. Their contributions help shape clinical best practices, support workforce development and strengthen the future of healthcare delivery.

During National PA Week, UCA proudly celebrates the Physician Associates whose dedication, compassion and expertise make a lasting difference every day. Thank you for the care you provide, the lives you impact and your commitment to advancing the Urgent Care profession.

Behind every great Urgent Care center are team members who go the extra mile. UCA and Experity are proud to recognize those remarkable individuals through the Staff Excellence Award at this year’s Limelight Awards.

If someone on your team consistently demonstrates excellence in patient care, teamwork and service, now is the time to give them the recognition they deserve. The nomination deadline is October 15, 2026. Don’t miss the opportunity to shine a spotlight on an outstanding colleague. Submit your nomination today.

The UCA Convergence 2027 Call for Proposals is now open, and we invite clinicians, operators, executives, educators, researchers, innovators, advocates and industry partners to help create an engaging and impactful learning experience for our community.

We’re looking for practical, credible and engaging contributions that help attendees:

We’re seeking contributors who can share real-world lessons, actionable strategies and practical solutions that attendees can immediately apply.

Important Dates

Submit your proposal by November 15.

As vaccine hesitancy continues to influence pediatric healthcare, a recent study examined the attitudes of families seeking care in Urgent Care centers. Researchers found that concerns about vaccine safety, effectiveness and necessity remain common, underscoring the ongoing challenges clinicians face when discussing immunizations with parents and caregivers.

The findings highlight the important role Urgent Care clinicians can play in building trust, addressing misinformation and supporting informed decision-making. By understanding the factors that contribute to vaccine hesitancy, clinicians can strengthen patient conversations and help improve confidence in recommended childhood vaccinations.

Ottehr is a revolutionary EHR for Urgent Care practices.

Our AI-enabled platform bundles all of the most important features – Ambient Scribe, AI-assisted charting/coding/billing, RCM support – into one low monthly fee on one platform.

Solutions.Vantage are sponsored content.

UCA’s Industry Perspectives series brings practical ideas, trends and insights from companies working alongside you in the Urgent Care space.

This issue spotlights bioMérieux’s video resource (60-min watch), Pathogen Surveillance Today: Why It Matters and Where We Need to Go (Episode 1), which explores how stronger surveillance, connected data sources and modernized reporting can help healthcare organizations improve situational awareness, identify emerging threats faster and make more informed operational and clinical decisions.

Industry Perspectives are sponsored content.

The College of Urgent Care Medicine is proud to welcome Lindsay Bishop, MSN, APRN, FNP, FCUCM, in our latest class of Fellows.

An experienced Nurse Practitioner and clinical leader, Lindsay has built an impressive career spanning Urgent Care, occupational medicine, clinical operations, quality improvement and clinician development. Throughout her career, she has successfully bridged frontline patient care with strategic leadership, helping organizations improve clinical performance, enhance quality and patient safety and strengthen clinician engagement and development.

Lindsay’s ability to connect organizational strategy with the realities of frontline care exemplifies the leadership, innovation and dedication recognized through Fellowship. We congratulate Lindsay Bishop, FCUCM, on this well-deserved achievement and welcome her as the newest Fellow of the College of Urgent Care Medicine

The College of Urgent Care Medicine is proud to welcome Christina Helsby Ray, MMSc, PA-C, FCUCM, in our latest class of Fellows.

Christina is an accomplished healthcare executive and clinical leader whose career has been dedicated to strengthening clinical operations, clinician development, quality improvement and patient care across the Urgent Care setting.

A collaborative and forward-thinking leader, Christina has played a key role in fostering strong partnerships between clinical teams, healthcare systems and operational leaders. Her dedication to clinical excellence, workforce development and innovation has helped shape the future of Urgent Care while maintaining a steadfast commitment to patient-centered care.

We congratulate Christina Helsby Ray, MMSc, PA-C, FCUCM, on this well-deserved achievement and look forward to her continued contributions to advancing Urgent Care medicine.

The College of Urgent Care Medicine is proud to welcome Colleen Marzilli, PhD, DNP, APRN, FNP-BC, NEA-BC, PHNA-BC, CNE, MedSurg-BC, CCM, FCUCM, in our latest class of Fellows.

Dr. Marzilli’s career reflects a remarkable dedication to healthcare leadership, nursing advocacy, academic excellence and patient care. An accomplished academic leader, Dr. Marzilli has served in faculty and program leadership roles, helping to develop innovative educational programs, support student success and advance evidence-based practice.

In addition to her academic and leadership accomplishments, Dr. Marzilli remains actively engaged in clinical practice, providing care across Urgent Care, primary care and emergency settings. Her commitment to quality improvement, clinician education, patient-centered care and professional advocacy has made a lasting impact on both the nursing profession and the communities she serves.

Through her leadership, scholarship, clinical excellence and dedication to developing future healthcare leaders, Dr. Marzilli exemplifies the values recognized through Fellowship. We congratulate Colleen Marzilli, PhD, DNP, APRN, FNP-BC, NEA-BC, PHNA-BC, CNE, MedSurg-BC, CCM, FCUCM, on this well-deserved achievement and celebrate the impact she continues to make across clinical practice, academia and healthcare leadership.

If you are interested in becoming a Fellow, use the link below.

When it comes to diagnostic testing, the right decision can have a significant impact on patient care, operational efficiency and your bottom line.

𝗕𝗲𝘆𝗼𝗻𝗱 𝘁𝗵𝗲 𝗦𝘄𝗮𝗯: 𝗠𝗮𝗸𝗶𝗻𝗴 𝗦𝗺𝗮𝗿𝘁𝗲𝗿 𝗧𝗲𝘀𝘁𝗶𝗻𝗴 𝗗𝗲𝗰𝗶𝘀𝗶𝗼𝗻𝘀 explores the real-world considerations behind building an effective testing strategy in Urgent Care. This on-demand course covers topics including CLIA-waived versus CLIA-moderate testing, common pitfalls, platform selection, reimbursement considerations, clinician education and more.

You’ll gain practical insights to help strengthen diagnostic decision-making and optimize testing in your center.

Explore this free resource and elevate your testing strategy

The College of Urgent Care Medicine (CUCM) and the Urgent Care College of Physicians (UCCOP) were proud to participate in this year’s Royal New Zealand College of Urgent Care (RNZCUC) Bootcamp and Fellowship Ceremony — an event made even more meaningful as RNZCUC marked its 25th year of Urgent Care’s recognition as a specialty. The occasion underscored the growing international momentum behind Urgent Care as a distinct clinical field.

A highlight of the program was a panel discussion on the global perspective of Urgent Care, featuring CUCM/UCCOP’s immediate past president Dr. Cesar Jaramillo and past president Dr. Chris Chao, Journal of Urgent Care Medicine’s (JUCM) Editor-in-Chief and CUCM/UCCOP President Dr. Lindsey Fish, and the Urgent Care Association’s President Dr. Cassandra Donnelly, alongside guests representing other countries. The conversation offered a rare side-by-side look at how Urgent Care is developing across different health systems, and where international colleges can learn from, support and collaborate with one another.

On the clinical education side, Dr. Chao delivered a well-received presentation, “Right Test, Right Patient, Right Time: Point-of-Care Testing for Respiratory Infections in Urgent Care,” sharing practical, evidence-based guidance for frontline Urgent Care clinicians.

The CUCM/UCCOP team also attended the Fellowship Ceremony, celebrating RNZCUC’s newest fellows, and took part in a research network workshop aimed at building collaborative infrastructure for Urgent Care research. JUCM’s continued participation added to a strong multi-organization presence at the event.

CUCM/UCCOP shared updates on the Colleges’ work and strategic planning, and explored avenues for future collaboration with international partners. The energy in the room was contagious; colleagues from around the world engaged deeply with topics directly shaping the future of Urgent Care practice, united by shared goals and a shared commitment to high-quality care.

Moments like this remind us why international representation matters so deeply to our specialty. Urgent Care looks different in every health system, and every delegation that crosses an ocean to sit at the same table brings back perspective, expertise and relationships that no single country could build alone.

Steve Sellars, Chief Executive Officer

For much of Urgent Care’s history, convenience was our calling card. Walk-in access, extended hours, seven-day availability, and locations close to where people live and work changed what patients expected from healthcare. Convenience helped build this field, but it won’t be the only thing defining our future.

Last month, I wrote about the forces reshaping healthcare: growing challenges with primary care access, rising costs, pressure on emergency departments, and employers searching for better ways to connect their workforce with affordable care. Those challenges create an enormous opportunity for Urgent Care, but they also ask more of us.

The next evolution of Urgent Care is about becoming an even stronger healthcare partner. That starts with recognizing what we do, and what we don’t do. Urgent Care isn’t a replacement for primary care. Patients need longitudinal relationships with primary care clinicians, particularly for chronic disease management and preventive care. Hospitals and emergency departments remain essential for patients requiring higher-acuity services. But between those settings is an enormous and growing need for timely, high-quality and affordable, everyday healthcare. That’s where Urgent Care excels.

Each day, approximately half a million patients turn to Urgent Care. Our clinicians evaluate illnesses and injuries, perform diagnostic testing, provide occupational health services, identify conditions requiring higher levels of care, and help patients determine what should happen next. That last part is increasingly important.

Being the front door to everyday healthcare isn’t simply about treating the patient in front of us. It’s about helping that patient move appropriately through a very complicated healthcare system. Imagine the opportunity when an Urgent Care visit more seamlessly connects a patient back to primary care, helps a health system avoid unnecessary emergency department utilization, gives an employer’s workforce faster access to appropriate care, or identifies a patient who needs more specialized treatment. In that model, our value extends beyond the individual visit.

For clinicians, this evolution reinforces the importance of clinical excellence, appropriate referrals, care coordination, and practicing at the top of our capabilities.

For operators, it creates opportunities to build stronger relationships with health systems, employers, payers, and other healthcare partners.

It also requires us to demonstrate our value. Access matters, but increasingly, our partners will expect evidence of quality, outcomes, appropriate utilization, patient experience, and cost. That’s why UCA’s work around Advocacy, benchmarking, quality standards, industry data, and initiatives like the Bring Congress to Urgent Care campaign is so important. Through that campaign, we’re inviting policymakers into our centers to see firsthand the quality, access, and value Urgent Care delivers to patients, communities, and the broader healthcare system. Together, these efforts help build the credibility required for Urgent Care to assume a larger role in healthcare delivery.

That credibility, and the relationships that support it, will be increasingly important moving forward. The organizations that thrive won’t simply be those that see the most patients or operate the most centers. They will be those that understand how Urgent Care fits into the larger healthcare ecosystem and build relationships that make the entire system work better.

We should be proud that convenience helped establish Urgent Care. Now we have an opportunity to build on it. Our next chapter is about becoming more connected, more measurable and more valuable to patients, employers, payers, and healthcare partners who increasingly depend on us. That’s how we move from being a convenient place to receive care to an indispensable partner in delivering it.

Risk of Post-acute Symptoms and Conditions After SARS-CoV-2 Compared to Other Respiratory Viral Infections: A Systematic Review and Meta-Analysis

Researchers pooled 14 cohort studies comparing lingering symptoms in adults after SARS-CoV-2 with those after other respiratory viruses, mostly influenza-like illness, influenza and RSV. Only a few outcomes were clearly more common after COVID: pulmonary embolism, abnormal breathing, fatigue, hemorrhagic stroke, brain fog and palpitations. Heart rate abnormalities were borderline, and most other outcomes were no more frequent than after other viral infections. The authors conclude that post-COVID condition is one example of a broader group of post-acute infection syndromes, not something entirely unique to SARS-CoV-2. Urgent Care Clinical implications: Clinicians should take persistent fatigue, dyspnea, palpitations, and cognitive complaints seriously after any respiratory virus, not just COVID. Keep PE and cardiopulmonary causes on the differential for patients with post-COVID breathing or heart symptoms. Full Access: International Journal of Infectious Diseases

Nationwide Increase in Reported Human Rabies Exposures: Rabies Post-exposure Prophylaxis Administration

CDC issued a Health Advisory on September 10 about a nationwide rise in rabies exposures and errors in post-exposure prophylaxis (PEP). Rabies inquiries to CDC were up 17% in July and August compared with last year, and use of rabies vaccine and HRIG rose about 33% and 76%. Supplies are fine, but mistakes lead to unnecessary treatment, adverse effects, and cost. The most common errors are gluteal vaccine injections, poor HRIG infiltration of wounds, mixing HRIG and vaccine in one syringe or site and giving HRIG to previously vaccinated patients. Urgent Care Clinical implications: Do a careful risk assessment before starting PEP, check prior vaccination and immune status and call your health department. Full Access: CDC

Deaths: Leading Causes for 2024

National Center for Health Statistics reports that the 10 leading causes accounted for 70.9% of all U.S. deaths in 2024, with the ranked order largely unchanged from 2023. Heart disease (22.2%) and malignant neoplasms (20.2%) remained first and second, followed by accidents/unintentional injuries (6.4%), cerebrovascular disease (5.4%), and chronic lower respiratory disease (4.7%). The most notable movement was suicide rising from 11th to 10th, while COVID-19 fell from 10th to 15th on a 37% year-over-year decline in deaths. Unintentional injury was the leading cause of death for every age group from 1 through 44 years. Urgent Care Clinical Implications: The dominance of unintentional injury across all working-age groups reinforces that trauma, overdose, and injury-related presentations are the highest-yield targets for risk assessment and intervention in the ambulatory and Urgent Care setting. Full Access: NVSS

Antibiotic Treatment and Antimicrobial Resistance in Urinary Tract Infections Among the Older Population in Denmark, 1999–2023

This national register-based surveillance study tracked prescribing of four UTI antibiotics (pivmecillinam, sulfamethizole, trimethoprim, nitrofurantoin) in Danes ≥70 years and resistance in E. coli and K. pneumoniae urine isolates. UTI antibiotic consumption peaked in 2014 and fell 28.4% by 2023, while resistance to all four agents declined significantly from 2018 to 2023 — trends the authors attribute to national stewardship initiatives begun after 2013. Notably, pivmecillinam use rose 3.5-fold yet its resistance fell, and the number of urine isolates rose over the period, hinting at more infections or more testing. The design is descriptive and ecological, so the stewardship-to-resistance link is correlational, not causal; the agents and the ≥70 primary-care/long-term-care population also limit US applicability. Urgent Care Clinical implications: The one portable, guideline-consistent takeaway is that pivmecillinam maintains low resistance despite heavy use and is a rational first-line agent for uncomplicated UTI. Full Access: Europe’s Journal on Infectious Disease

New Syphilis Tools App

Frontline clinicians are likely finding that diagnosing syphilis can be challenging — limited time, competing priorities, and complex diagnostics make it hard to act confidently and quickly. That is exactly why CDC funded this project and partnership with the University of Washington. Syphilis Tools is a new, free app that healthcare providers can use as a clinical reference for syphilis screening, testing, and treatment. Urgent Care Clinical Implications: Clinician can use interactive tools within the app to interpret serologic tests, identify syphilis stages, determine treatment regimens, and monitor titers, all from one app. Full Access: CDC

24 AI tools ranked for patient safety: Stanford, Harvard study

Stanford and Harvard researchers benchmarked 24 AI systems (20 generalist LLMs and 4 retrieval-augmented clinical tools) on 1,100 real physician-to-specialist consult cases, scored by 29 board-certified physicians. The four medical-specific tools (AMBOSS LiSA, Doximity Ask, OpenEvidence, Glass Health) tied for best, with potentially severe harmful errors in 2.9-5.4% of cases, versus roughly 9-25% for the generalist models. More than 80% of severe errors were omissions (recommending too little) rather than harmful actions. Urgent Care implications: Clinical decision support in Urgent Care should favor evidence-grounded, medical-specific tools over general chatbots, and since omission is the dominant failure mode, clinicians should use AI to check for missed workup, follow-up, and referral steps rather than as a sole answer. AI should be used carefully and should not replace evidence-based recommendations. Full Access: Becker Hospital Review

Consistency Key to Managing Pediatric Constipation

At AAP 2026, pediatric GI specialist, argued that managing pediatric constipation depends on consistency. Treatment starts with an effective disimpaction (oral PEG or magnesium citrate, sometimes with a stimulant laxative, often done at home). Otherwise, softener alone can cause leakage around retained stool, and families wrongly conclude it isn’t working. Maintenance therapy then aims for a soft stool daily, paired with scheduled toilet sits, foot-stool positioning, and rewards for behaviors the child controls, such as taking medication and sitting. Recovery can take months to years, so written green/yellow/red action plans and school bathroom accommodations help prevent relapse. Urgent Care Clinical Implications: Urgent Care visits often catch children at the impaction or overflow-soiling stage, so offering a home cleanout plan and clear counseling that fiber or a short softener course alone won’t fix it can prevent repeat visits. Give a written action plan and arrange prompt PCP follow-up to carry the maintenance phase. Full Access: Contemporary Pediatrics

Post-Treatment Vaginal Microbiota Predicts Bacterial Vaginosis Recurrence in Concurrently Treated Couples

This post-hoc pooled analysis gave women standard 7-day oral metronidazole and their male partners oral metronidazole plus topical 2% clindamycin. Repeat BV at 4 weeks was 20.7%, well below the 46% in the untreated-partner control arm of the StepUp trial. Women whose Nugent score was still 4-10 on day 8, before resuming sex, had about 2.8 times the risk of repeat BV (about 35% vs 12%). IUD users trended toward higher risk. The authors conclude that re-infection and persistence of BV-associated organisms are distinct, overlapping pathways, and that partner treatment only addresses the first. Urgent Care Clinical Implications: For recurrent BV, partner treatment will not fix persistence, so repeating the same regimen in a woman who never cleared is likely to fail, and a short-interval recheck before resuming sex may identify those women. Full Access: The Lancet

October 22, 2026

Now featured on UC Compass, the UC Ready designation recognizes Urgent Care organizations that have adopted a structured, standards-aligned approach to assessing and supporting clinician readiness during onboarding. The designation highlights employers that are committed to helping clinicians build the knowledge, skills and confidence needed to thrive in the Urgent Care environment. Make sure to filter “UC ready” to see your list of options

For job seekers, UC Ready serves as a trusted indicator that an organization values professional development and has invested in a thoughtful onboarding process. For employers, it offers a way to demonstrate their commitment to workforce excellence, quality care and continuous improvement. As Urgent Care continues to grow and evolve, initiatives like UC Ready help connect talented clinicians with organizations dedicated to setting them up for success from day one.

Register now and find your people

Help shape what comes next for Urgent Care at UCA Convergence 2027.

We’re inviting clinicians, operators, executives, researchers, educators, innovators, advocates and industry partners to propose practical, credible and engaging contributions that can help the Urgent Care community make better decisions, improve care, strengthen organizations and advance the field.

Have expertise, evidence, experience, research or a tested approach to share? 𝗦𝘂𝗯𝗺𝗶𝘁 𝘆𝗼𝘂𝗿 𝗽𝗿𝗼𝗽𝗼𝘀𝗮𝗹 𝗯𝘆 𝗡𝗼𝘃𝗲𝗺𝗯𝗲𝗿 𝟭𝟱.

UCA’s Industry Perspectives series brings practical ideas, trends, and insights from companies working alongside you in the Urgent Care space. Procedures stall when room setup depends on memory.

In this free Industry Perspectives article, Bionix® and Owen Dahl show how standardized readiness, including illuminated tools, ReadyHub™ staging and preparation guidance, helps Urgent Care teams prepare consistently on every shift.

Industry Perspectives are sponsored content.

The College of Urgent Care Medicine is proud to welcome David A. Miller, MD, MHA, CHCEF, FCUCM, FAAFP, in our latest class of Fellows.

Dr. Miller brings more than 30 years of experience in medicine, with a career spanning primary care, Urgent Care, clinical leadership, and healthcare administration. A longtime advocate for accessible, high-quality care, he developed and implemented an Urgent Care program at a federally qualified community health center and spent more than a decade providing clinical and administrative leadership for the program.

Throughout his career, Dr. Miller has balanced patient care with broader healthcare leadership. He currently serves as a healthcare executive overseeing a wide range of clinical and operational services while continuing to practice as an Urgent Care provider. His experience also extends to emergency management, disaster relief, physician leadership, and community service.

A dedicated leader within the medical profession, Dr. Miller has held leadership positions in professional organizations and has been recognized for his contributions to Family Medicine, including being named Missouri Family Physician of the Year in 2021.

Dr. Miller’s longstanding dedication to patient care, clinical leadership, community service, and the advancement of Urgent Care reflects the values recognized through Fellowship. We are proud to welcome David A. Miller, MD, MHA, CHCEF, FCUCM, FAAFP, as a Fellow of the College of Urgent Care Medicine.

The College of Urgent Care Medicine is proud to welcome Katlyn Poupore, MSN, FNP-BC, FCUCM, in our latest class of Fellows.

An experienced Family Nurse Practitioner and healthcare leader, Katlyn has built her career around advancing clinical excellence, strengthening healthcare operations, and supporting the growth and development of advanced practice providers. Her experience spans Urgent Care, occupational health, family medicine, and emergency medicine, giving her a broad perspective on delivering high-quality, patient-centered care.

Throughout her career, Katlyn has led initiatives focused on clinical quality, operational performance, workforce planning, and provider development. She has also played an important role in developing fellowship and academic programs, mentoring advanced practice providers and nursing students, and creating evidence-based educational initiatives that support professional growth and clinical excellence.

With a collaborative approach to leadership, Katlyn is committed to connecting organizational strategy with frontline patient care while creating opportunities for clinicians to learn, grow, and succeed. She is currently pursuing a Doctor of Nursing Practice to further strengthen her expertise in clinical leadership.

Katlyn’s dedication to clinical excellence, education, innovation, and the advancement of healthcare professionals reflects the values recognized through Fellowship. We are proud to welcome Katlyn Poupore, MSN, FNP-BC, FCUCM, as a Fellow of the College of Urgent Care Medicine.

Urgent Caring, the quarterly peer-reviewed publication of the Urgent Care College of Physicians (UCCOP) in collaboration with the College of Urgent Care Medicine (CUCM), is now accepting submissions for First Quarter 2027 and future issues.

Urgent Care is its own specialty — and the people who know it best are the ones practicing it every day. That’s you.

We accept submissions on a rolling basis. Send your work whenever it’s ready, and we’ll place it in an upcoming issue.

Feature articles we’re looking for:

Short pieces — we want these too!

Not every contribution needs to be a full article. These short items help fill out each issue, and they’re a great way to get involved:

Peer reviewers wanted!

We’re also looking for members willing to review submissions. It’s a great way to sharpen your own writing and give back to the specialty.

Why publish with Urgent Caring?

How to submit: Visit the link below and include your name, credentials, affiliation and a short title.

Want to run an idea by us first? Reach out — we’re happy to help you shape a topic.

Information for Authors

Articles submitted to Urgent Caring should be no longer than two pages, excluding images and references. Submissions are accepted on a rolling basis and will be published at the discretion of the editors in an upcoming issue.

Use of Artificial Intelligence

Urgent Caring allows the responsible use of artificial intelligence (AI), when it is under the following recommendations: :

Original human thought. The central idea of every article, its essence, must be the original thinking of the author(s), not generated by AI. The majority of the article must be written by the author(s), and all content must be reviewed, verified, and approved by them before submission.

Authorship. AI tools may not be listed or cited as authors. They cannot take responsibility for the work, approve the final version, declare conflicts of interest, or enter into copyright agreements.

Acceptable uses. AI may be used in a supporting role, such as checking spelling and grammar, formatting, assisting with literature searches, or improving clarity. It should not be used to generate an article’s concept, arguments, or conclusions.

Disclosure. Any use of AI beyond the acceptable uses described above, such as creating or altering images and graphics or collecting and analyzing data, must be disclosed at submission and in the article, naming the tool, its version, and how it was used.

Accountability. Authors are fully responsible for everything in their article, including any portion produced with AI assistance. This includes confirming that every reference is real and correctly cited and that no content is plagiarized. Undisclosed or inappropriate AI use will be treated as a breach of publication ethics

Let’s keep building the evidence base for Urgent Care — by Urgent Care.

Tracey Quail Davidoff, MD, FCUCM, and Cesar Mora Jaramillo, MD, FAAFP, FCUCM

Editors-in-Chief, Urgent Caring

Urgent Updates are curated highlights of guidelines, reviewed by (and some directly coming from) Urgent Care clinicians. These highlights represent the actual intent of these articles and how they relate to the practice of Urgent Care medicine.

Sebastien leads commercial operations across the Americas and oversees Freightos’ global airline portfolio. With over a decade of executive aviation and air cargo experience, including leadership roles at Air Canada Cargo across revenue management, strategic alliances, and digital transformation, Sebastien brings deep operational and commercial perspective to modern freight digitization.

Executive Abstract & Discussion Overview

In this edition of Freight Thoughts, Judah Levine sits down with Sebastien Podgorski to explore the structural shifts happening across air cargo procurement.

While the last decade focused on digitizing search, dynamic rates, and e-bookings, the next industry frontier is about procurement intelligence. Across this three-part video series, Sebastien breaks down:

Why Peak Season Exposes Your Freight Procurement Vulnerabilities

- Peak Season Exposes Flaws

Peak demand does not create procurement problems. It exposes existing operational friction that teams ignore during stable periods.

- The Static vs. Dynamic Paradox

Air freight operates in a highly dynamic market, yet many forwarders still manage procurement using static spreadsheets, manual rate checks, and siloed communication.

- Contract vs. Spot Execution

The challenge isn’t choosing between long-term allocations or spot rates; it’s having the real-time data needed to know precisely when to utilize each.

- Data Context over Human Stitching

Highly skilled logistics professionals currently spend excessive time manually connecting fragmented data sources instead of focusing on commercial strategy.

Why Peak Season Exposes Your Freight Procurement Vulnerabilities

- Peak Season Exposes Flaws

Peak demand does not create procurement problems. It exposes existing operational friction that teams ignore during stable periods.

- The Static vs. Dynamic Paradox

Air freight operates in a highly dynamic market, yet many forwarders still manage procurement using static spreadsheets, manual rate checks, and siloed communication.

- Contract vs. Spot Execution

The challenge isn’t choosing between long-term allocations or spot rates; it’s having the real-time data needed to know precisely when to utilize each.

- Data Context over Human Stitching

Highly skilled logistics professionals currently spend excessive time manually connecting fragmented data sources instead of focusing on commercial strategy.

Why Peak Season Exposes Your Freight Procurement Vulnerabilities

- Peak Season Exposes Flaws

Peak demand does not create procurement problems. It exposes existing operational friction that teams ignore during stable periods.

- The Static vs. Dynamic Paradox

Air freight operates in a highly dynamic market, yet many forwarders still manage procurement using static spreadsheets, manual rate checks, and siloed communication.

- Contract vs. Spot Execution

The challenge isn’t choosing between long-term allocations or spot rates; it’s having the real-time data needed to know precisely when to utilize each.

- Data Context over Human Stitching

Highly skilled logistics professionals currently spend excessive time manually connecting fragmented data sources instead of focusing on commercial strategy.

Weekly highlights

Ocean rates – Freightos Baltic Index

- Asia-US West Coast prices (FBX01 Weekly) were level

- Asia-US East Coast prices (FBX03 Weekly) increased 1%

- Asia-N. Europe prices (FBX11 Weekly) increased 6%

- Asia-Mediterranean prices (FBX13 Weekly) increased 3%

Air rates – Freightos Air Index

- China – N. America weekly prices increased 19%

- China – N. Europe weekly prices increased 8%

- N. Europe – N. America weekly prices increased 2%

Analysis

Trends in international ocean logistics seem even more confusing than usual lately: more Iranian attacks but more Hormuz traffic; more crude exports but oil prices still around $100 per barrel; more risk of Houthi attacks on passing ships, but more container vessels returning to the Red Sea anyway.

Iran has stepped up the frequency of attacks on vessels around the Strait of Hormuz, partially because transits and crude flows through the waterway have increased in recent weeks. Last week an Iranian projectile sunk a Dubai-linked container vessel, indicating that even some container ships are taking the risk of transiting the strait, though most traffic still comprises tankers.

Despite some estimates that the increase in tankers exiting the Persian Gulf is contributing to Middle East crude exports approaching pre-war levels, crude prices – still pricing in elevated risk – remain high.

Houthi-Saudi violence is intensifying, with recent Houthi advances along the Red Sea increasing its potential leverage over maritime traffic through the Bab el-Mandeb Strait and the likelihood of attacks on passing vessels.

Despite that heightened risk – which since late 2023 had been enough to divert the vast majority of container traffic away from the Red Sea – container carriers continue their steady march back through the Suez, with estimates that transits will fully recover during Q1 of the coming year.

Why carriers are more comfortable going back now than during similar, earlier high-risk stretches is a good question. The answer is probably a mix of high current fuel costs and congestion levels with evolving geopolitical considerations. These considerations may include, as Peter Tirschwell recently pointed out, Houthi interest in security and stability for most Red Sea traffic that could somewhat legitimize the group in relation to the West – alongside increased pressure directed at Saudi Arabia and its passing vessels.

Whatever the reasons, that the Red Sea container rebound is happening gradually instead of all at once should mitigate the extent of schedule disruptions and vessel bunching that will occur as more vessels arrive earlier than slotted. That this restoration unfolded post the early-July Asia – Europe demand peak, and will continue through the coming low demand months will also mean less disruption to shippers than if the return coincided with peak season.

Current port congestion levels – though backlogs and delays are finally easing at Far East hubs – continues to absorb some container capacity, and will help carriers maintain rate levels even as effective capacity increases from vessels circulating more quickly via the Red Sea. Overall though, the Red Sea return – if geopolitics allow its completion – increases the overcapacity risk for carriers in 2027.

At the moment, even with Red Sea-driven effective capacity increases and slumping demand on Asia – Europe trades, spot rates are recently trending up on these lanes after months of declines.

Asia – N. Europe Freightos Baltic Index rates climbed 6% last week to $3,442/FEU and prices to the Mediterranean increased 3% to $3,927/FEU on recent GRIs aimed at putting pressure on rates as 2027 long term contract negotiations get underway. Some forwarders are skeptical however, that increases will stick given current market conditions.

Transpacific ocean rates were stable but still highly elevated last week at $8,126/FEU to the West Coast, with prices up 1% to $9,700/FEU for the East Coast. Daily rates so far this week are showing signs of increase – despite expectations that volumes are finally cooling – possibly due to capacity reductions as the lanes enter slow season.

Last month some carriers announced plans for significant transatlantic container price increases in October. So far though transatlantic spot rates have increased only about $200/FEU to $2,850/FEU since the end of September. Prices are however 25% higher than a year ago, possibly reflecting upward pressure from elevated bunker costs.

In air cargo, the EU is set to introduce a November 1st €2 small parcel handling fee on top of the €3 customs surcharge introduced in July for low value imports that previously entered via the de minimis exemption. This additional fee could increase the China – Europe e-commerce volume draw down seen since July, which has led to some downward pressure on air cargo rates and shifted freighter capacity to other lanes.

Freightos Air Index data show ex-China rates increased last week, possibly on a post-Golden Week backlog rebound or signalling the start of peak season pressure. Prices posted a sharp 19% gain to $6.88/kg to the US and an 8% climb to $3.87/kg to Europe.

But while the global benchmark is 30% higher than a year ago on elevated fuel costs and volume growth – with transpacific rates 25% higher year on year – Asia – Europe prices are down 3% compared to last October, possibly reflecting e-commerce volume adjustments on this lane.

Freightos Terminal™: Real-time pricing dashboards to benchmark rates and track market trends.

Procure™: Streamlined procurement and cost savings with digital rate management and automated workflows.

Rate, Book, & Manage™: Real-time rate comparison, instant booking, and easy tracking at every shipment stage.

Getinge Interim Report July-September 2026: Increased profitability, strong cash flow and higher customer satisfaction

GOTHENBURG, Sweden, Oct. 21, 2026 /PRNewswire/ -- "We delivered organic growth both in order intake and in sales during the quarter, at the same time we increased profitability and generated strong cash flow." says Mattias Perjos, President & CEO of Getinge.

Sales growth was primarily driven by Acute Care Therapies while Surgical Workflows contributed with a stable order intake, mainly within operating room equipment.

The situation for Life Science remains mixed – the high-margin Sterile Transfer category performed strongly, while the project-based and capital-intensive product category of WIS, which includes washer-disinfectors, was impacted by the persistently low level of investment activity in the pharma segment," says Mattias Perjos, President & CEO of Getinge.

The adjusted EBITA margin strengthened sharply, rising to 15.1%, and was positively impacted by tariff refunds of SEK 45 M and year-on-year currency effects of approximately SEK 36 M. Even excluding these factors, the margin improved by more than 1 percentage point to 14.3%, which reflects the sustained positive underlying performance of the operations.

"The improvement was driven by a favorable mix, price discipline and productivity improvements. Improved profitability, together with a positive development in working capital, contributed to strong cash flow," says Perjos.

In the latter part of the quarter Getinge initiated the launch of Cardiohelp II – the medtech company's next generation ECLS therapy platform – in CE countries and Hong Kong. Customer feedback has been positive.

"We also received 510(k) clearance for a new Edi catheter, which can be used together with our ventilators to support breathing for premature infants weighing as little as 500-1000 grams," tells Perjos. "It is increasingly important for us as a trusted partner in healthcare to show how our solutions can help increase productivity."

During the quarter, Torin Plan Optimizer launched, an AI-powered system designed to manage resources more efficiently and make surgical workflows more predictable during surgeries.

"Getinge's greatest strength lies in the work my colleagues around the world do every day in close collaboration with our customers. Against the backdrop of an uncertain global environment, I am therefore particularly pleased that we have achieved all-time highs in both customer satisfaction and employee engagement. At the same time, our ongoing dialogue with customers supports our decision to maintain our outlook for organic net sales growth of 3–5% for the full year 2026," concludes Perjos.

July-September 2026 in brief

- Net sales increased organically by 2.1% (9.5) and the order intake rose by 2.6% organically (4.7)

- Adjusted gross profit amounted to SEK 4,343 M (4,051) and the margin was 51.4% (49.2)

- Adjusted EBITA was SEK 1,278 M (1,079) and the margin 15.1% (13.1)

- Adjusted earnings per share amounted to SEK 3.10 (2.42)

- Free cash flow amounted to SEK 1,302 M (793)

Phone Conference

A conference call will be held on October 21, at 10.00-11.00 a.m. CEST hosted by Mattias Perjos, President & CEO, and Agneta Palmér, CFO.

To participate via teleconference, please register via this link. After registration, you will be provided with telephone numbers and a conference ID to access the conference. You can ask questions verbally via the telephone conference.

During the conference call a presentation will be held. To access the presentation through webcast, please use this link. A recorded version can be accessed here for 3 years.

Contact information:

David Kördel, Head of Investor Relations

Phone: +46(0)10 335 0077

E-mail: [email protected]

This information is such that Getinge AB is obliged to make public pursuant to the EU Market Abuse Regulation and the Swedish Securities Market Act. The information was submitted for publication, through the agency of the contact person set out above, on October 21, 2026, at 08.00 CEST.

About Getinge

With a firm belief that every person and community should have access to the best possible care, Getinge provides hospitals and life science institutions with products and solutions that aim to improve clinical results and optimize workflows. The offering includes products and solutions for intensive care, cardiovascular procedures, operating rooms, sterile reprocessing and life science. Getinge employs approximately 12,000 people worldwide and the products are sold in more than 135 countries.

This information was brought to you by Cision http://news.cision.com

The following files are available for download:

SOURCE Getinge

Share this article

WuXi Biologics Receives Top-Honor Jade Award at The Asset Corporate Sustainability Leadership Awards 2026

- Also Named Best in Transition (Hong Kong)

- Recognized for ESG Leadership and Green and Digital Transformation

SHANGHAI, Oct. 21, 2026 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), today announced that it received the top-honor Jade Award at The Asset Corporate Sustainability Leadership Awards 2026, as well as the Best in Transition (Hong Kong) award. WuXi Biologics is the only pharmaceutical company among this year's Jade Award recipients.

The Jade Award — the program's highest distinction — is conferred on organizations that integrate sustainability into strategy and operations, and demonstrate outstanding leadership in governance, resilience, innovation, transformation and long-term value creation. For WuXi Biologics, the award reflects recognition from investors and the industry of the company's continued enhancement of ESG governance, commitment to transparent and responsible global operations, and use of sustainability to strengthen long-term competitiveness.

Dr. Chris Chen, CEO of WuXi Biologics and Chairman of its ESG Committee, commented, "We are honored to receive this recognition from The Asset. Sustainability is integral to our mission of enabling our clients and benefiting patients. WuXi Biologics will continue to strengthen ESG governance and advance its Green CRDMO solutions. Through innovation and responsible operations, we aim to support the pharmaceutical industry's green transition while working with global partners to create long-term value."

WuXi Biologics has established a four-tier governance structure led by its ESG Committee. This integrated management framework spans strategy formulation, resource allocation, professional implementation and business execution, embedding sustainability into strategic decision-making and day-to-day operations. The Company's advanced ESG governance and sustainability performance have earned global recognition, including an MSCI AAA rating, an EcoVadis Platinum Medal, and Morningstar Sustainalytics' highest "Negligible Risk" rating and recognition as an Industry and Regional ESG Leader, as well as inclusion in the Dow Jones Best-in-Class World Index and Emerging Markets Index.

The Asset Corporate Sustainability Leadership Awards' Best in Transition award further recognizes WuXi Biologics' progress in green and digital transformation. Through its end-to-end Green CRDMO solutions, the Company embeds green principles throughout the biologics research, development and manufacturing lifecycle. It continuously enhances resource efficiency and environmental performance through Green technology innovation, energy efficiency, renewable energy adoption and value-chain collaboration. WuXi Biologics also integrates digitalization with sustainability through a digital Smart ESG management platform, which strengthens data integration, dynamic monitoring and analysis, improving ESG information management efficiency and decision quality to support long-term sustainable development.

About WuXi Biologics

WuXi Biologics (stock code: 2269.HK) is a leading global Contract Research, Development and Manufacturing Organization (CRDMO) offering end-to-end solutions that enable partners to discover, develop and manufacture biologics – from concept to commercialization – for the benefit of patients worldwide*.

With over 14,000 employees in China, the United States, Ireland, Germany, and Singapore, including experts and scientists in biologics R&D and manufacturing, technology innovation, and operational excellence, WuXi Biologics leverages its technologies and expertise to deliver efficient, cost-effective, and scalable biologics solutions tailored to meet clients' needs. By embedding digital capability and infrastructure across the full biopharmaceutical value chain, the company turns data, computation, and prediction into transparent client experience, faster development, intelligent operations, and more efficient manufacturing. As of June 30, 2026, WuXi Biologics is supporting 1064 integrated client projects, including 78 in Phase III and 28 in commercial manufacturing, with complex modalities representing more than half of the entire project portfolio.

WuXi Biologics regards sustainability as the cornerstone of long-term business growth. The company continuously drives technology innovations to offer advanced end-to-end Green CRDMO solutions for its global partners while demonstrating exemplary Environmental, Social and Governance (ESG) practices. Committed to creating shared value, it collaborates with all stakeholders to foster positive social and environmental impacts, and promote responsible practices that empower the entire value chain.

For more information about WuXi Biologics, please visit: www.wuxibiologics.com.

*The winner of the "2026 Biologics CDMO of the Year" (Large CDMOs) (Life Science Connect / Outsourced Pharma)

*The winner of the "2026 Best Contract Development & Manufacturing Organization Award" (ABEA)

Contacts

Media

[email protected]

SOURCE WuXi Biologics

Share this article